Severe community-acquired pneumonia.
Niederman MS, Torres A.
Eur Respir Rev. 2022 Dec 14;31(166):220123. doi: 10.1183/16000617.0123-2022. Print 2022 Dec 31.
Community-acquired pneumonia.
Aliberti S, Dela Cruz CS, Amati F, Sotgiu G, Restrepo MI.
Lancet. 2021 Sep 4;398(10303):906-919. doi: 10.1016/S0140-6736(21)00630-9.
[Community-acquired pneumonia].
Seeger A, Rohde G.
Dtsch Med Wochenschr. 2023 Mar;148(6):335-341. doi: 10.1055/a-1940-8944. Epub 2023 Mar 6.
Updates on community acquired pneumonia management in the ICU.
Nair GB, Niederman MS.
Pharmacol Ther. 2021 Jan;217:107663. doi: 10.1016/j.pharmthera.2020.107663. Epub 2020 Aug 15.
Community-Acquired Pneumonia.
Rider AC, Frazee BW.
Emerg Med Clin North Am. 2018 Nov;36(4):665-683. doi: 10.1016/j.emc.2018.07.001. Epub 2018 Sep 6.
Advancements in the Management of Severe Community-Acquired Pneumonia: A Comprehensive Narrative Review.
Davis D, Thadhani J, Choudhary V, Nausheem R, Vallejo-Zambrano CR, Mohammad Arifuddin B, Ali M, Carson BJ, Kanwal F, Nagarajan L.
Cureus. 2023 Oct 12;15(10):e46893. doi: 10.7759/cureus.46893. eCollection 2023 Oct.
Community-acquired pneumonia: Strategies for triage and treatment.
Modi AR, Kovacs CS.
Cleve Clin J Med. 2020 Mar;87(3):145-151. doi: 10.3949/ccjm.87a.19067.
Ceftaroline in severe community-acquired pneumonia.
Cilloniz C, Pericàs JM, Rojas J.
Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):28-30. doi: 10.37201/req/s01.06.2022. Epub 2022 Apr 22.
Community-acquired pneumonia: Epidemiology, diagnosis, prognostic severity scales, and new therapeutic options.
Oliveira E Silva PG, Cerqueira Batista Filho LA, Ismael PF, Victoria VES, Alexandre TM, Larissa SM.
Medwave. 2023 Dec 7;23(11):e2719. doi: 10.5867/medwave.2023.11.2719.
Community-acquired pneumonia among children: the latest evidence for an updated management.
Nascimento-Carvalho CM.
J Pediatr (Rio J). 2020 Mar-Apr;96 Suppl 1(Suppl 1):29-38. doi: 10.1016/j.jped.2019.08.003. Epub 2019 Sep 10.
